CompletedNCT02009826
Official study titlePhase 0 Clinical Protocol: A Longitudinal and Multimodal Exploratory Study to Evaluate a Neuroinflammatory Hypothesis in Patients With Schizophrenia Compared to Young Healthy Subjects
This study has finished and is no longer accepting participants.
Multiple locations, including BoechoutSchizophreniaObservational studyAges 18–40
- Countries
- Belgium
- Sponsor
- Universiteit Antwerpen
Active Not RecruitingNCT05333003
Official study titleSemaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity for Metformin Non-responders: a Single-blind Randomized Control Trial
This study is no longer accepting new participants.
In TorontoSchizophreniaMedication studyAges 18–70
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT02069925
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenSchizophreniaBehavioural studyAges 16–35
- Countries
- United States
- Sponsor
- Yale University
TerminatedNCT04140773
This study ended early.
In BaselSchizophreniaPlacebo comparisonAges 18–50
- Countries
- Switzerland
- Sponsor
- Dragos Inta
WithdrawnNCT03994965
Official study titleIdentification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-principle Study
This study was withdrawn before enrollment.
Location not clearly listedSchizophreniaMedication studyAges 18–45
- Countries
- Sponsor
- Bjorn H. Ebdrup
CompletedNCT01364792
Official study titleA Double Blind Placebo Controlled Study of Valaciclovir in Treatment of Psychosis in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In GroningenSchizophreniaMedication studyAges 18+
- Countries
- Netherlands
- Sponsor
- University Medical Center Groningen
Active Not RecruitingNCT03442101
Official study titleTrajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study in Medication-naïve First Episode Psychosis Patients
This study is no longer accepting new participants.
In BirminghamSchizophreniaObservational studyAges 17–35
- Countries
- United States
- Sponsor
- University of Alabama at Birmingham
TerminatedNCT00757497
Official study titleSafety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)
This study ended early.
In BethesdaSchizophreniaBehavioural studyAges 10+
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT06043206
Official study titleBariatric Surgery in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BarcelonaSchizophreniaObservational study
- Countries
- Spain
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
CompletedNCT05500651
Official study titleThe Effect of Dance and Movement Therapy as a Group Work Technique on Negative Symptoms and Disability in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In AmasyaSchizophreniaInterventional study
- Countries
- Türkiye
- Sponsor
- Amasya University
CompletedACTRN12620001309976
Official study titleResistance training versus aerobic interval training in a rehabilitation setting for people living with psychotic disorders: a randomised controllled trial
This study has finished and is no longer accepting participants.
Multiple locations, including WoolloongabbaSchizophreniaInterventional studyAges 18–64
- Countries
- Australia
- Sponsor
- Dr Nicole Korman
CompletedNCT04432688
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingSchizophreniaObservational study
- Countries
- China
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.